Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pouteria ramiflora extract is a plant-derived extract obtained from the leaves, stem bark, or root bark of *Pouteria ramiflora* (Mart.) Radlk., a tree in the Sapotaceae family native to Brazil and commonly known as "curriola." It is traditionally used in Brazilian folk medicine for treatment of worm infections, dysentery, pain, inflammation, hyperlipidemia, and obesity. The extract contains high levels of flavonoids (notably myricetin glycosides), phenolic compounds, tannins, triterpenes, anthraquinones, coumarins, and other secondary metabolites[1][2][3]. Research indicates it can inhibit alpha-amylase *in vitro* and reduce blood glucose in animal models, suggesting utility in glycemic control. It also has demonstrated mild cytotoxicity in tumor cell lines, antioxidant properties, and potential chemopreventive and antimutagenic actions, likely due to its content of myricetin, gallic acid, and anthraquinones[1][2][3][5]. Its safety in humans has not been fully established[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pouteria ramiflora extract.